baber/WOPTO huggingface dataset:
Patent DK-1775507-T3 (DK)
IPC: F16L13/14
Filed: 2005-10-12
Granted: 2008-06-30
Abstract: A pipeline fitting has at least one connector (1) to fit to the end of the pipeline. There are at least two holding ribs (4) round the connector to hold the pipeline end (2) being fitted in or on it. Each holding rib contains at least one axial flow channel (5), the one in one rib being offset from that in the other.
Patent DK-1588948-T3 (DK)
Inventor: MASAKATSU KONDO
IPC: B67C3/22
Filed: 2005-04-15
Granted: 2010-06-07
Abstract: A liquid filling nozzle comprises a vertical tubular nozzle body 11 having a discharge opening 27 at a lower end thereof, and an upwardly or downwardly movable plug 41 for opening or closing the discharge opening 27. The plug 41 is provided with a seal portion 51 disposed at the lower end of an outer peripheral wall thereof and shaped in conformity with the shape of the discharge opening 27. The seal portion 51 is provided with a spreader portion 52 positioned thereabove and tapered upward. The spreader portion 52 is so shaped that the liquid to be filled and discharged from the opening 27 is cause to spread by the spreader portion 52 toward a direction closer to a horizontal and as shifted from a direction close to a vertical, as the seal portion 51 is moved away from the discharge opening 27.
Patent DK-1733042-T3 (DK)
Inventor: COTTICELLI GIOVANNI
IPC: C12P41/00
Filed: 2005-04-07
Granted: 2008-09-08
Abstract: A process for preparing an intermediate for synthesizing escitalopram and the pharmaceutically acceptable salts thereof from 4-(4-dimethylamino)-1-(4'-fluorophenyl)-1-(hydroxybutyl)-3-(acyloxymethyl)benzonitrile is described. The process involves converting said intermediate into the (S+) enantiomer of citalopram by means of enzymatic enantiomeric resolution.
Patent DK-1745287-T3 (DK)
Inventor: AHEARN JOSEPH M
IPC: G01N33/569
Filed: 2005-05-11
Granted: 2011-01-24
Abstract: The invention relates to methods of monitoring immunologic, hematologic and inflammatory diseases or conditions by determining levels of components of the complement pathway on the surface of white blood cells.
Patent DK-1719511-T3 (DK)
Inventor: LINDSTROM KYLE J
IPC: G01N33/15
Filed: 2002-11-14
Granted: 2009-04-14
Abstract: N -[4-(4-amino-2-ethyl-1 H -imidazo[4,5- c ]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof.
Patent DK-1866292-T3 (DK)
Inventor: YANG SHANGJIN
IPC: C07D487/04
Filed: 2006-03-31
Granted: 2011-05-09
Abstract: The invention relates to novel tricyclic 1,2,4-triazine-1-oxides and novel tricyclic 1,2,4-triazine-1,4-dioxides of formula I and to related analogues, to their preparation, and to their use as hypoxia-selective drugs and radiosensitizers for cancer therapy, both alone or in combination with radiation and/or other anticancer drugs.
Patent DK-1956150-T3 (DK)
Inventor: CHEN QIYUE
IPC: E03C1/04
Filed: 2007-05-04
Granted: 2009-09-28
Abstract: The present invention relates to a temperature control faucet with an improved structure in the valve technical field. The temperature control faucet addresses the defects existing in the prior art of inconvenient control and narrow range of use. The temperature control faucet of the invention comprises a valve body (1) which has two inflow conduits (1a) and an outflow conduit (1b), and a temperature control valve (2) set in the valve body. The temperature control valve is arranged at the convergence of cold water and hot water of the inflow conduits within the cavity of the valve body. The temperature control valve is linked with a turn handle (3) out of the valve body. A flow valve (4) is provided at one end of the outflow conduit of the valve body to control the flow rate. The temperate and the flow rate could be separately controlled by the temperature control faucet with an improved structure of the invention. Therefore, the faucet is conveniently used, and has a small volume and a wide range of use.
Patent DK-1981374-T3 (DK)
Inventor: COLUCCI DAVID A
IPC: G05D23/00
Filed: 2007-02-09
Granted: 2012-01-02
Abstract: An equipment storage rack includes a housing defining an interior region. The housing has an exterior. At least one piece of electronic equipment is supported by the housing within the interior region. A management system is adapted to monitor and display conditions of the equipment storage rack. In a certain configuration, the management system includes a controller unit mounted within the interior region of the housing, a display unit coupled to the controller unit and mounted on the exterior of the housing, and at least one monitoring device, coupled with the controller unit, to monitor at least one parameter of the equipment storage rack. Methods of controlling an equipment storage rack are further disclosed.
Patent DK-2213301-T3 (DK)
Inventor: ISHIBASHI MASAKI
IPC: A61K38/20
Filed: 2008-10-23
Granted: 2018-01-22
Abstract: An immunity-inducing agent comprising as an effective ingredient a specific polypeptide is disclosed. These polypeptides were isolated, by the SEREX method using a cDNA library derived from canine testis and serum from a cancer-bearing dog, as a polypeptide which binds to an antibody existing specifically in serum derived from a cancer-bearing living body. The polypeptides can induce immunity in a living body and cause regression of a tumor in a cancer-bearing living body. Therefore, these polypeptides are especially effective as a therapeutic and/or prophylactic agent for a cancer(s).
Patent DK-2296488-T3 (DK)
Inventor: DELPORTE CHRISTIAN
IPC: A23J3/18
Filed: 2009-07-06
Granted: 2012-07-30
Abstract: The present invention relates to protein pellets including wheat gluten, characterized in that the gluten has: a water retention capacity, determined according to a test A, of between 40 and 160%, preferably between 100 and 150%; and a viscoelastic behaviour, according to the Chopin Alveograph, determined at a P/L parameter value of between 3 and 10, preferably between 3 and 8.
Patent DK-2178331-T3 (DK)
Inventor: MONTOJO JUAN
IPC: H04W68/00
Filed: 2007-04-27
Granted: 2012-05-14
Abstract: Techniques for paging user equipments (UEs) in a wireless communication system are described. In one aspect, a cell sends a paging indicator on a shared control channel to a UE and sends a page message on a shared data channel to the UE. The paging indicator and page message may be sent from multiple cells to the UE. Alternatively, the paging indicator may be sent from multiple cells to the UE, and the page message may be sent from a single cell to the UE.
Patent DK-2266422-T3 (DK)
Inventor: SPEELMANS GELSKE
IPC: A61K31/733
Filed: 2005-05-17
Granted: 2019-11-25
Abstract: The present invention relates to the field of prebiotics. Provided are uses for compositions comprising synergistically effective amounts of polyfructose and galactooligosaccharides (GOS).
Patent DK-2805473-T3 (DK)
Inventor: WHARTON JAMES
IPC: H04L29/08
Filed: 2013-01-15
Granted: 2018-05-07
Abstract: A cloud management node (102) in a public cloud (100) works together with a private management system (116) in a private cloud (114) to manage provisioning and access to cloud services from the private cloud (114). Private data does not need to be held or duplicated in the public cloud so that the data security is enhanced. The private management system (116) issues tokens for authorization so that user access to cloud services may be controlled. The cloud management node (102) receives provisioning requests from the private cloud (114) and selects and informs an appropriate service provider node (112) that a provisioning request is waiting. In examples an administrator at the private cloud (114) is able to manage cloud service access for many users in a simple effective manner and users are able to operate multiple cloud services from a single account.
Patent DK-2976337-T3 (DK)
Inventor: NIROGI RAMAKRISHNA
IPC: C07D405/14
Filed: 2013-10-18
Granted: 2018-07-16
Abstract: The present invention relates to novel quinoline compounds of formula (I), and their pharmaceutically acceptable salts and process for their preparation. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptor agonists.
Patent DK-3022210-T3 (DK)
Inventor: HIMMELSBACH FRANK
IPC: C07D519/00
Filed: 2014-07-14
Granted: 2018-06-06
Abstract: The present invention relates to compounds of general formula (I), wherein the group R1, R2, X and Y are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the AMP-activated protein kinase (AMPK) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
Patent DK-3166925-T3 (DK)
Inventor: JOHNS BRIAN ALVIN
IPC: C07D407/10
Filed: 2015-07-06
Granted: 2018-06-18
Abstract: Compounds of Formula I are disclosed and methods of treating viral infections with compositions comprising such compounds.
Patent DK-0392250-T3 (DK)
Inventor: LINDNER WOLFGANG DR
IPC: C09D5/14
Filed: 1990-03-26
Granted: 1993-09-27
Abstract: The liquid preservative contains 1,2-benzoisothiazolin-3-one and an alkyl(polyaminoalkyl)glycine in a weight ratio of (3.5 to 100) : 1 and is suitable for preserving plastics dispersions.
Patent DK-0416282-T3 (DK)
Inventor: GROEGER ULRICH DR
IPC: C12R1/01
Filed: 1990-07-31
Granted: 1994-10-17
Abstract: The invention relates to a microbiologically produced, heat-stable N-acyl-L-proline acylase and to a process for obtaining it from Comamonas testosteroni DSM 5416 or Acaligenes denitrificans DSM 5417. The enzyme can be used to obtain L-proline from N-acetyl-D,L-proline, N-chloroacetyl-D,L-proline, N-formyl-D,L-proline, N-propionyl-D,L-proline, N-butyryl-D,L-proline, N-valeryl-D,L-proline, N-caproyl-D,L-proline, to obtain L-thiazolidine-4-carboxylic acid from N-acetyl-D,L-thiazolidine-4-carboxylic acid or N-chloroacetyl-D,L-thiazolidine-4-carboxylic acid, to obtain L-thiazolidine-2-carboxylic acid from N-acetyl-D,L-thiazolidine-2-carboxylic acid or N-chloroacetyl-D,L-thiazolidine-2-carboxylic acid, and L-pipecolic acid from N-acetyl-D,L-pipecolic acid or N-chloroacetyl-D,L-pipecolic acid. The enzyme can also be employed to produce N-acetyl-L-proline, N-propionyl-L-proline and N-butyryl-L-proline from L-proline and the relevant carboxylic acid.
Patent DK-0487757-T3 (DK)
Inventor: HECK ERNST
IPC: A23P30/25
Filed: 1990-11-26
Granted: 1995-10-30
Abstract: A co-extruded cooked product 3 is cut by die stamping between two cylinders 7 and 8, in a zone in which the casing of the product is still thermoplastic, by two moulds having cutting lines which interact in order to produce shearing of the said product. 
<??>Application to the production of products of any form obtained by co-extrusion cooking. 
<IMAGE>
Patent DK-0446475-T3 (DK)
Inventor: KLEINKORRES UWE
IPC: H02G3/04
Filed: 1990-12-21
Granted: 1995-03-27
Abstract: The invention relates to a cable channel, such as wall trunking, apparatus moulding channel or the like. The housing of such a cable channel has an opening, which can be closed by a cover, on one side. At least one side wall of the cable channel and also the outside of its base has continuous grooves, each having a groove opening whose boundary walls are equipped in places with coupling projections. According to the invention, it is proposed to fit mating couplings of a holder 31 for convection-grid profiles 50 to these coupling projections. Such a holder 31 for convection-grid profiles 50 is constructed in the form of a honeycomb. In this case, each honeycomb consists of walls and lateral walls which are arranged in pairs at a distance from one another. Each honeycomb bounds a space 49. The mating couplings are allocated to the one wall of the pair 34 of walls, and at least one retaining space 41 for a convection-grid profile 50 is allocated to the one lateral wall 36 of the pair of lateral walls.
Patent DK-0389372-T3 (DK)
Inventor: FREMAUX JACQUES
IPC: F24F1/00
Filed: 1990-03-22
Granted: 1995-06-19
Abstract: The invention concerns a heating window using the parietal-dynamic effect. 
<??>The opening frame of a conventional window (22) is fitted with an inner heating over-glazing (9, 10). Air (24, 25) circulates between the glazing of the opening frame and the over-glazing. It penetrates from the exterior through aperatures in the lower section of the opening frame and then emerges into the interior of the room from the upper section. 
<IMAGE>
Patent DK-0455052-T3 (DK)
Inventor: KUEKENHOEHNER THOMAS DR
IPC: C07D413/14
Filed: 1991-04-18
Granted: 1994-09-05
Abstract: 5-(1,2,4-Triazol-1-yl-methyl)-isoxazolines I   <IMAGE> I  where R1 and R2 are each H, alkoxyalkyl, haloalkyl, alkyl, cycloalkylalkyl, phenylalkyl, naphthylalkyl, cycloalkyl, phenyl, naphthyl or hetaryl, where the aryl and hetaryl moieties of the stated substituents may furthermore carry an unsubstituted or halogen-substituted phenyl or phenoxy radical or up to 3 of the following radicals: halogen, CN, NO2, alkyl, haloalkyl or alkoxy, and the salts and metal complexes of I are suitable as fungicides and for regulating plant growth.
Patent DK-0479436-T3 (DK)
Inventor: GILLIS HERBERT RUSSELL
IPC: C08K5/29
Filed: 1991-09-10
Granted: 1998-09-07
Abstract: Internal mould release compositions suitable for use in the production of moulded articles by the RIM process, comprises a blend of a metal salt of an organic acid and a polysiloxane polymer having isocyanate reactive organic groups and optionally a compatibilizing amount of an amidine or imidate compound.
Patent DK-0437415-T3 (DK)
Inventor: IBRAHIM JUTTA DR
IPC: C07D487/04
Filed: 1991-01-03
Granted: 1995-09-18
Abstract: The invention relates to a novel crystalline form, containing water of crystallization, of 4-(5,6,7,8-tetrahydroimidazol[1,5-a] pyridin-5-yl)-benzonitrile hydrochloride of formula Ia   <IMAGE> (Ia) and to a process for the preparation thereof. The novel crystalline form is distinguished by excellent storage stability.
Patent DK-0542206-T3 (DK)
Inventor: BEDERKE KLAUS DR
IPC: C09D133/14
Filed: 1992-11-11
Granted: 1996-02-12
Abstract: 2.1. The invention relates to a binder composition for solvent-containing or aqueous coating compositions which cure at low temperature to give yellowing-free and solvent-resistant coatings. 2.2. The binder composition contains binder components based on polyethers, polyesters, polyether-polyesters and/or (meth)acrylic copolymers, each containing at least one acryloyl group and at least one epoxide group in the molecule, where the acryloyl groups and epoxide groups are present in a number ratio of from 2 : 8 to 8 : 2, and one or more polyamines as curing agent in a ratio between the equivalent weights of from 2 : 0.5 to 1 : 1.5. 2.3. Binders for pigmented and pigment-free paints (surface coatings, lacquers, enamels, varnishes), in particular for use in multicoat finishes.
Patent DK-0499580-T3 (DK)
Inventor: WINKELJANN ANTONIUS
IPC: B25B27/02
Filed: 1992-01-31
Granted: 1995-10-09
Abstract: The extraction tool (1) for expanding sleeves (2) of anchors consists of a shank (1a) which has a conical external thread (1b) tapering towards one, free end and carries a force-application means (1c) at the other end. The shank (1a) has a central passage bore (1d), extending in the longitudinal direction, for receiving anchor bolts (4). After relieving the expanding sleeve (2) by axially driving in the anchor bolt (4), the extraction tool (1) can be screwed, by way of its external thread (1b), into the gap between the anchor bolt (4) and the expanding sleeve (2). By screwing in the extraction tool (1), the external thread (1b) cuts into the internal wall (2b) of the expanding sleeve (2) and thus forms a positive connection. By applying an axial force to the force-application means (1c), the expanding sleeve (2) can be extracted from the drill hole (9) of the receiving material (3). 
<IMAGE>
Patent DK-0516797-T3 (DK)
Inventor: WOLFF M KIRSCH
IPC: A61B17/12
Filed: 1991-12-19
Granted: 1999-06-23
Abstract: A medical anastomosis sling for use in the repair or regeneration of nerves. Nerve ends are placed in a breathable semiporous membrane having sets of elongate and wide tabs which are secured and sealed around the ends via circumferential fasteners and surgical clips for securing and sealing the sling in position without the necessity of suturing the device for optimal anastomosis.
Patent DK-0569822-T3 (DK)
Inventor: GUILLOT GERARD LOUIS HENRI
IPC: D06F75/18
Filed: 1993-05-04
Granted: 1996-03-11
Abstract: The invention relates to an electric steam iron comprising a housing (1), the rear of which forms a heel (2), and a sole (3) heated by an electrical resistor (4) and having a partition (5) forming, with a closing plate (6), an evaporation chamber (7) which comprises a so-called descaling orifice (11) opening into a rear part of the iron and plugged by removably mounted closing means. According to the invention, the closing means comprise a removable lime-recovering receptacle (12) communicating via a baffle (13) with the evaporation chamber (7), in such a way that the lime present in the evaporation chamber (7) falls into the receptacle (12), particularly when the iron rests on its heel. <IMAGE>
Patent DK-0571602-T3 (DK)
Inventor: LIND PETER
IPC: C12P21/04
Filed: 1992-12-11
Granted: 2003-10-06
Abstract: PCT No. PCT/SE92/00858 Sec. 371 Date Nov. 4, 1993 Sec. 102(e) Date Nov. 4, 1993 PCT Filed Dec. 11, 1992 PCT Pub. No. WO93/12143 PCT Pub. Date Jun. 24, 1993Substantially pure dimers of Apolipoprotein Al-Milano (Al-M/APO Al-M) isolated and characterized from plasma are provided. Pharmaceutical compositions comprising the Apo Al-M/Apo Al-M are also provided. Apolipoprotein Al-M dimer can be produced in a recombinant Escherichia coli system or collected from plasma from Apolipoprotein Al-Milano carriers. Atherosclerosis and cardiovascular diseases can be treated with the dimer. Medicaments containing the dimer can also be used for preventing thrombosis in different clinical circumstances, both at the arterial and at the venous level. The dimer can also act as a prodrug for the monomer.
Patent DK-0648122-T3 (DK)
Inventor: ABERMAN HAROLD M
IPC: A61P43/00
Filed: 1993-04-02
Granted: 1996-12-09
Abstract: A method of modifying salts of alginic acid in situ for prevention and treatment of various intra-articular and extra-articular (spine) complications modifies the alginate in situ to an insoluble gel. This in situ modification provides a final product which can be compressed within the intra-articular space thus remaining localized. The modified material can have varied mechanical strengths and thus varied degradation times and can serve as a matrix for localizing and slowly releasing therapeutic agents. The modified material is biocompatible and biodegradable, thus requiring no reoperation for removal.
Patent DK-0597088-T3 (DK)
Inventor: TERTIUK WASYL
IPC: C07D233/84
Filed: 1993-01-08
Granted: 2001-04-09
Abstract: PCT No. PCT/FR93/00015 Sec. 371 Date Jan. 28, 1994 Sec. 102(e) Date Jan. 28, 1994 PCT Filed Jan. 8, 1993 PCT Pub. No. WO93/14070 PCT Pub. Date Jul. 22, 1993A compound selected from the group consisting of a compound of the formula    <IMAGE>  IA  anded as in the specification having antagonist properties to histamine H3-receptors.
Patent DK-0659958-T3 (DK)
Inventor: OSTHEIMER TIBOR
IPC: B62H3/12
Filed: 1994-12-10
Granted: 1998-05-25
Abstract: The carousel-type bicycle hanger assembled in accordance with the modular construction principle exhibits two running rails 1, 2 which are spaced apart from one another in parallel and are connected to intermediate frames 5, 6 which can be extended as required, provision being made on both sides for termination frames 5', 6' which, for their part, retain semicircular upper and lower bearing elements 3, 4 and 3', 4'. The running rails 1, 2, which run both at the top and at the bottom, are arranged in parallel in each case. Individual bicycle cages 8, which are moved by means of a conveying chain drive 7, are suspended in said running rails 1, 2. <IMAGE>
Patent DK-0641621-T3 (DK)
Inventor: OBRIST BASIL
IPC: B23H7/26
Filed: 1994-08-31
Granted: 1998-05-25
Abstract: The rotary drive device for the drive of the sleeve of an electrical discharge machining unit comprises an electric motor, reversible with regard to the direction of rotation, and a reduction gear unit allocated to the electric motor. This reduction gear unit has a pinion (41) and two gear wheels (33, 35) rotatably mounted relative to one another. Both the gear wheels (33, 35) mesh with the pinion (41). One of the gear wheels (35) is under the effect of a torsion preloading force. A first gear wheel (33) of the two gear wheels of the reduction gear unit is coupled to the sleeve (20, 21) in such a way as to be locked in terms of rotation, while the second gear wheel (35) is rotatable relative to the sleeve. Such a rotary drive device works with little effort in both directions of rotation absolutely free of play, any wear which may arise being automatically compensated for. <IMAGE>
Patent DK-0686081-T3 (DK)
Inventor: DE CUYPER DIRK
IPC: B29C49/06
Filed: 1994-01-20
Granted: 1999-10-11
Abstract: PCT No. PCT/BE94/00007 Sec. 371 Date Jul. 19, 1995 Sec. 102(e) Date Jul. 19, 1995 PCT Filed Jan. 20, 1994 PCT Pub. No. WO94/16871 PCT Pub. Date Aug. 4, 1994Method for manufacturing plastic objects, in particular preforms, in which the raw material for manufacturing said objects is injected into a mould, in which said objects are cooled for hardening said injected raw material to a solid object and in that the manufactured objects are removed from the mould by means of two gripper elements (41, 42) and apparatus therefor.
Patent DK-0684842-T3 (DK)
Inventor: KLATZMANN DAVID
IPC: A61K35/76
Filed: 1994-02-21
Granted: 2001-06-18
Abstract: Compsn. for treating tumours in humans and animals (and for immunising against tumours) comprises a synergistic combination of (1) cells, viruses or bacteria that express, transiently in the organism, at least one gene for an immunomodulator and (2) viruses (or cells producing them) that preferentially infect dividing cells in the treated organism and carry in their genome at least one gene expression of which can be lethal to such cells. Partic. the cells expressing immunomodulator and producing virus are the same. In a modification, component (1) can be replaced by any other system for delivering immunomodulator, e.g. a micropump.
Patent DK-0718295-T3 (DK)
Inventor: ROSINI GOFFREDO
IPC: A61K31/365
Filed: 1995-11-27
Granted: 1999-01-11
Abstract: Lactones of formula <CHEM> and their pharmacologically acceptable salts endowed with antioxiding and hypolipidaemic properties and that show the capability to prevent and/or to delay the oxidative modification of the lipoproteins by competing with the chain of propagation of the lipidic peroxidation by means of an effective scavenging of the peroxylic radicals. The derivatives object of the present invention are useful in the treatment of the atherosclerosis and of many correlated vascular pathologies, like ischaemic cardiopathies (angina pectoris and myocardial infarction), cerebral thrombosis and peripheral arteriopathies, because the high plasma levels of lipids and the oxidative modifications of the low density lipoproteins (LDL) represent crucial events in the pathogenesis of the atherosclerosis.
Patent DK-0679574-T3 (DK)
Inventor: PY DANIEL
IPC: B65B55/02
Filed: 1995-04-11
Granted: 2000-10-23
Abstract: The procedure uses a sealed container (1) which has at least one part (2B) made from material which can be pierced by a hollow needle (8R). The material has sufficient elasticity so as to be able to reseal itself after the needle has been withdrawn from it. The hollow needle is connected to a fluid supply, and as the needle punctures the material and the container is filled, it is held in an aseptic environment (7). This is achieved using a laminar flow. <IMAGE>